Medication info
Gunil Glimepiride Tablet 2 mg

Gunil Glimepiride Tablet 2 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Gunil Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200300334 · Notified 2003.03.26 · Insurance code 646800030

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is taken orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medicine in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, a change in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start treatment with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily, whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Gunil Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise regimens to help manage blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with oral hypoglycemic agents or insulin. In particular, it may be used in conjunction with sulfonylureas or metformin when blood sugar control is difficult. These treatment methods enable effective management of blood sugar and assist in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is taken orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medicine in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, a change in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start treatment with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily, whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or patients in a coma. Additionally, patients with allergies to this drug, its ingredients, or sulfonylureas should not receive it. There is no experience with this medication in patients with severe liver or renal impairment, thus transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as breastfeeding women, are advised against taking this medication. Patients with severe infections, preoperative or postoperative conditions, or severe trauma should also receive insulin therapy. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious due to the risk of hypoglycemia from impaired food absorption. This medication contains lactose, thus, patients with lactose intolerance or certain genetic metabolic disorders should avoid it. During the first week of taking this medication, there is a higher risk of hypoglycemia, so blood sugar levels should be closely monitored. Older adults, those with poor nutritional status, individuals who skip meals, and those with irregular eating habits are more susceptible to hypoglycemia. If there is an imbalance between muscle activity and carbohydrate intake, the risk of hypoglycemia also increases. Patients who frequently consume alcohol or those with impaired kidney or liver function, as well as patients with other endocrine disorders, should also exercise caution. If this medication is overdosed or taken with other drugs, blood sugar control may be affected, so caution is advised. If hypoglycemic symptoms appear, it is important to immediately consume sugars, and if symptoms are severe, consult a medical professional. This medication can cause hypoglycemia, with symptoms that may include headaches, severe hunger, nausea, fatigue, confusion, drowsiness, and in more severe cases loss of consciousness. Temporary blurred vision or indigestion, liver function abnormalities, and rare blood abnormalities and allergic reactions may also occur. If allergic symptoms such as hives, itching, or difficulty breathing occur, immediate medical attention should be sought. If severe adverse reactions occur, discontinue use and seek prompt medical treatment. While taking this medication, concurrent dietary and exercise regimens are important for blood sugar control, and it is crucial to take it regularly. In case of hypoglycemia, sugar or sugary drinks should be consumed immediately, as artificial sweeteners are ineffective. Additionally, during stressful situations, surgery, or infection, where blood sugar control is difficult, temporary transition to insulin therapy may be necessary. If taking other medications or starting new ones, it is essential to inform the physician or pharmacist about potential interactions with this medication. Special attention is required when taking it with certain antibiotics, antifungals, beta-blockers, steroids, and anticoagulants, as blood sugar changes may occur. Pregnant or breastfeeding women are recommended to switch to insulin therapy, as this medication may pose risks to the fetus or newborn. The safety and efficacy of this medication in children under 18 years of age have not been established, thus its use in this population is discouraged. In older adults, caution should be exercised regarding dosage adjustments due to potential renal function decline. In the event of an overdose, severe hypoglycemia may occur, and immediate medical treatment should be sought. When storing this medication, it should be kept in a tightly closed container, out of reach of children, and in its original container to maintain its quality and safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, speech anomalies, aphasia, visual impairment, tremors, incomplete paralysis, sensory anomalies, dizziness, weakness, loss of self-control, transient mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, elevated liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to avoid exposure to air or moisture. It is advisable to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.